US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

CervoMed

2.93

-0.0400-1.35%

Pre-market: 2.970.0392+1.34%09:00 EDT

Volume:175.07K

Turnover:512.33K

Market Cap:44.30M

PE:-0.92

High:2.98

Open:2.98

Low:2.86

Close:2.97

52wk High:10.00

52wk Low:2.13

Shares:15.12M

Float Shares:9.60M

Volume Ratio:0.73

T/O Rate:1.82%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-3.1959

EPS(LYR):-2.9824

ROE:-107.62%

ROA:-60.80%

PB:1.93

PE(LYR):-0.98

Loading ...

Overview Company News Filings

CervoMed Receives Notice of Allowance for Neflamapimod Patent in Dementia With Lewy Bodies

MT Newswires Live

CervoMed - Patent Expected to Provide Ip Protection Into 2042

THOMSON REUTERS

CervoMed Secures New U.S. Patent Protecting Use of Neflamapimod in Pure Dementia With Lewy Body Patients Into 2042

THOMSON REUTERS

CervoMed wins U.S. patent allowance for neflamapimod use in pure Lewy body dementia into 2042

Top Midday Gainers

MT Newswires Live

CervoMed Jumps 29% Pre-Bell After Reporting to SEC Insider Purchase Worth $3 Million Late Monday

MT Newswires Live

Major Insider Move at CervoMed Signals Strong Confidence From the Top

CervoMed Posts Updated Investor Presentation and Business Overview

CervoMed beneficial owner Joshua S. Boger acquires 955,414 common shares for $2,999,999.96

CervoMed to Participate in the H.C. Wainwright 7th Annual Neuro Perspectives Expert Summit

Roth MKM Reaffirms Their Buy Rating on CervoMed (CRVO)

CervoMed Announces Private Placement to Advance Neurology Pipeline

CervoMed releases corporate presentation highlighting neflamapimod Phase 2b efficacy signal in dementia with Lewy bodies

CervoMed announces $10.5M private placement

CervoMed prices unregistered $10.5 million private placement at $3.14 per unit

CervoMed - Announces Private Placement With Anticipated Gross Proceeds of $10.5 Mln

THOMSON REUTERS

CervoMed Announces Private Placement Financing and Plan to Focus on Strategic Partnering to Advance Neflamapimod Into Phase 3 for Dementia With Lewy Bodies

THOMSON REUTERS

Press Release: CervoMed Announces Private Placement Financing and Plan to Focus on Strategic Partnering to Advance Neflamapimod into Phase 3 for Dementia with Lewy Bodies

CervoMed Shareholders Back Board, Pay and Incentive Plan

CervoMed shareholders approve Amendment No. 1 to 2025 equity incentive plan at annual meeting

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg1.tigeractivity.com/stock/CRVO/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CRVO","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CRVO\",,,,,undefined,":{"symbol":"CRVO","market":"US","secType":"STK","nameCN":"CervoMed","latestPrice":2.93,"timestamp":1790884800000,"preClose":2.97,"halted":0,"volume":175071,"hourTrading":{"tag":"盘前","latestPrice":2.9692,"preClose":2.93,"latestTime":"09:00 EDT","volume":3341,"amount":9690.6366518,"timestamp":1790946032675,"change":0.0392,"changeRate":0.013379,"amplitude":0.038191},"delay":0,"changeRate":-0.01346801346801348,"floatShares":9604400,"shares":15119100,"eps":-3.195903,"marketStatus":"Pre-Mkt","change":-0.04,"latestTime":"10-02 09:11:32 EDT","open":2.98,"high":2.98,"low":2.86,"amount":512330.6105502,"amplitude":0.040404,"askPrice":2.98,"askSize":250,"bidPrice":2.89,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-3.195903,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1790947800000},"marketStatusCode":1,"adr":0,"exchange":"NASDAQ","adjPreClose":2.93,"preHourTrading":{"tag":"盘前","latestPrice":2.9692,"preClose":2.93,"latestTime":"09:00 EDT","volume":3341,"amount":9690.6366518,"timestamp":1790946032675,"change":0.0392,"changeRate":0.013379,"amplitude":0.038191},"postHourTrading":{"tag":"盘后","latestPrice":2.9299,"preClose":2.93,"latestTime":"19:53 EDT","volume":3288,"amount":9583.9653,"timestamp":1790898798187,"change":-0.0001,"changeRate":-0.000034,"amplitude":0.010239},"volumeRatio":0.7297714360576762},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CRVO\",,,,,undefined,":{"symbol":"CRVO","floatShares":9604400,"roa":"-60.80%","roe":"-107.62%","lyrEps":-2.982424,"volumeRatio":0.7297714360576762,"shares":15119100,"dividePrice":0,"high":2.98,"amplitude":0.040404,"preClose":2.97,"low":2.86,"week52Low":2.13,"pbRate":"1.93","psRate":"133.71","week52High":10,"institutionHeld":0,"latestPrice":2.93,"committee":-0.428571,"eps":-3.195903,"divideRate":0,"volume":175071,"delay":0,"ttmEps":-3.195903,"open":2.98,"prevYearClose":7.9,"prevWeekClose":2.54,"prevMonthClose":2.97,"prevQuarterClose":2.97,"fiveDayClose":2.52,"twentyDayClose":2.64,"sixtyDayClose":3.41},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CRVO\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-07","symbol":"CRVO","fiscalQuarterEnding":"2026/06","expectedEps":-0.87,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1786075200000,"reportTimeType":"post","actualEps":-0.64},{"market":"US","date":"2026-05-15","symbol":"CRVO","fiscalQuarterEnding":"2026/03","expectedEps":-0.9,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1778817600000,"reportTimeType":"pre","actualEps":-0.86},{"market":"US","date":"2026-03-13","symbol":"CRVO","fiscalQuarterEnding":"2025/12","expectedEps":-0.79,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1773374400000,"reportTimeType":"post","actualEps":-0.88},{"market":"US","date":"2025-11-07","symbol":"CRVO","fiscalQuarterEnding":"2025/09","expectedEps":-0.68,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1762491600000,"reportTimeType":"post","actualEps":-0.84},{"market":"US","date":"2025-08-08","symbol":"CRVO","fiscalQuarterEnding":"2025/06","expectedEps":-0.57,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1754625600000,"reportTimeType":"pre","actualEps":-0.7}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CRVO\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CRVO\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":6,"updateTime":1766116800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CRVO\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CRVO","date":"2026-10-01","current":-0.916799,"percent":0.814044,"low":-119.682483,"twenty":-31.775497,"median":-3.946365,"eighty":-1.506059,"high":-0.69356,"avg":-16.215902,"sd":23.024931,"marketCap":44903715},"quantilePoints":[{"date":"2023-09-01","current":-5.788607,"twenty":-5.849231,"median":-5.813052,"eighty":-5.769051,"marketCap":33591560},{"date":"2023-09-08","current":-5.135433,"twenty":-5.817941,"median":-5.700604,"eighty":-4.975855,"marketCap":29801161},{"date":"2023-09-15","current":-4.791246,"twenty":-5.769051,"median":-5.182368,"eighty":-4.935961,"marketCap":27803825},{"date":"2023-09-22","current":-4.51746,"twenty":-5.708427,"median":-5.1589,"eighty":-4.822536,"marketCap":26215035},{"date":"2023-09-29","current":-4.66902,"twenty":-5.505043,"median":-5.045475,"eighty":-4.536234,"marketCap":27094543},{"date":"2023-10-06","current":-5.250814,"twenty":-5.262548,"median":-5.040586,"eighty":-4.536234,"marketCap":30470722},{"date":"2023-10-13","current":-6.893527,"twenty":-5.817941,"median":-5.065031,"eighty":-4.595684,"marketCap":40003462},{"date":"2023-10-20","current":-8.995809,"twenty":-6.690143,"median":-5.197035,"eighty":-4.691783,"marketCap":52203100},{"date":"2023-10-27","current":-9.201148,"twenty":-7.153624,"median":-5.22148,"eighty":-4.714546,"marketCap":53394692},{"date":"2023-11-03","current":-8.379791,"twenty":-8.309389,"median":-5.27037,"eighty":-4.77036,"marketCap":48628322},{"date":"2023-11-10","current":-9.709606,"twenty":-8.530373,"median":-5.764162,"eighty":-4.78929,"marketCap":56345302},{"date":"2023-11-17","current":-41.851906,"twenty":-9.287195,"median":-5.866832,"eighty":-4.791246,"marketCap":55950767},{"date":"2023-11-24","current":-43.761983,"twenty":-9.977525,"median":-6.385068,"eighty":-4.83818,"marketCap":58504301},{"date":"2023-12-01","current":-41.597229,"twenty":-22.855354,"median":-7.177091,"eighty":-4.969206,"marketCap":55610296},{"date":"2023-12-08","current":-37.39506,"twenty":-39.737313,"median":-7.68555,"eighty":-5.041564,"marketCap":49992521},{"date":"2023-12-15","current":-37.352614,"twenty":-39.16082,"median":-8.389569,"eighty":-5.054275,"marketCap":49935776},{"date":"2023-12-22","current":-28.736045,"twenty":-38.685423,"median":-8.477572,"eighty":-5.063075,"marketCap":38416500},{"date":"2023-12-29","current":-26.825968,"twenty":-38.401034,"median":-8.868694,"eighty":-5.079111,"marketCap":35862966},{"date":"2024-01-05","current":-39.899383,"twenty":-38.549596,"median":-9.044699,"eighty":-5.121353,"marketCap":53340488},{"date":"2024-01-12","current":-39.88198,"twenty":-39.488419,"median":-9.670494,"eighty":-5.172981,"marketCap":53317222},{"date":"2024-01-19","current":-38.625999,"twenty":-39.313626,"median":-10.04206,"eighty":-5.199968,"marketCap":51638132},{"date":"2024-01-26","current":-38.965567,"twenty":-39.313626,"median":-10.775414,"eighty":-5.223436,"marketCap":52092093},{"date":"2024-02-02","current":-34.593614,"twenty":-39.237223,"median":-27.727949,"eighty":-5.242992,"marketCap":46247338},{"date":"2024-02-09","current":-43.719537,"twenty":-39.237223,"median":-28.736045,"eighty":-5.262548,"marketCap":58447556},{"date":"2024-02-16","current":-68.677874,"twenty":-39.888941,"median":-31.961952,"eighty":-5.505043,"marketCap":91813733},{"date":"2024-02-23","current":-59.169936,"twenty":-40.466999,"median":-34.275268,"eighty":-5.692782,"marketCap":79102808},{"date":"2024-03-01","current":-63.372175,"twenty":-41.597229,"median":-35.401364,"eighty":-5.759273,"marketCap":84720676},{"date":"2024-03-08","current":-73.849585,"twenty":-41.945287,"median":-36.142899,"eighty":-5.808163,"marketCap":98727664},{"date":"2024-03-15","current":-76.245081,"twenty":-43.210183,"median":-36.501144,"eighty":-5.849231,"marketCap":101930142},{"date":"2024-03-22","current":-103.758666,"twenty":-50.901256,"median":-37.320992,"eighty":-6.027192,"marketCap":138712367},{"date":"2024-03-28","current":-90.558053,"twenty":-57.709789,"median":-37.373837,"eighty":-6.291199,"marketCap":121064797},{"date":"2024-04-05","current":-61.481111,"twenty":-59.566286,"median":-37.479952,"eighty":-6.48676,"marketCap":133529165},{"date":"2024-04-12","current":-71.595379,"twenty":-59.997513,"median":-38.212361,"eighty":-6.942417,"marketCap":155496070},{"date":"2024-04-19","current":-71.737433,"twenty":-62.930842,"median":-38.413768,"eighty":-7.153624,"marketCap":155804594},{"date":"2024-04-26","current":-94.969175,"twenty":-65.856384,"median":-38.647222,"eighty":-7.237715,"marketCap":206260987},{"date":"2024-05-03","current":-91.738931,"twenty":-67.584491,"median":-38.965567,"eighty":-7.396119,"marketCap":199245307},{"date":"2024-05-10","current":-90.826862,"twenty":-70.379394,"median":-39.220244,"eighty":-7.806798,"marketCap":197264409},{"date":"2024-05-17","current":-48.426621,"twenty":-71.185147,"median":-39.390029,"eighty":-8.309389,"marketCap":201061130},{"date":"2024-05-24","current":-37.632017,"twenty":-70.941929,"median":-39.252477,"eighty":-8.383702,"marketCap":156243317},{"date":"2024-05-31","current":-37.651896,"twenty":-70.600999,"median":-39.231253,"eighty":-8.399347,"marketCap":156325854},{"date":"2024-06-07","current":-38.148885,"twenty":-69.492975,"median":-39.142864,"eighty":-8.458016,"marketCap":158389289},{"date":"2024-06-14","current":-37.791053,"twenty":-68.677874,"median":-39.132924,"eighty":-8.477572,"marketCap":156903616},{"date":"2024-06-21","current":-39.600094,"twenty":-68.284435,"median":-39.132924,"eighty":-8.688778,"marketCap":164414520},{"date":"2024-06-28","current":-34.033815,"twenty":-67.93606,"median":-39.122984,"eighty":-8.944963,"marketCap":141304045},{"date":"2024-07-05","current":-30.813326,"twenty":-67.00636,"median":-39.083225,"eighty":-9.025143,"marketCap":127932985},{"date":"2024-07-12","current":-31.707906,"twenty":-66.374913,"median":-38.90211,"eighty":-9.138568,"marketCap":131647168},{"date":"2024-07-19","current":-32.304293,"twenty":-66.254136,"median":-38.668445,"eighty":-9.459288,"marketCap":134123291},{"date":"2024-07-26","current":-27.89103,"twenty":-66.009803,"median":-38.625997,"eighty":-9.678316,"marketCap":115799986},{"date":"2024-08-02","current":-21.131978,"twenty":-65.799563,"median":-38.413768,"eighty":-9.715473,"marketCap":87737266},{"date":"2024-08-09","current":-18.460659,"twenty":-64.992694,"median":-38.255401,"eighty":-10.106595,"marketCap":93102198},{"date":"2024-08-16","current":-29.88401,"twenty":-63.82037,"median":-38.148885,"eighty":-10.558342,"marketCap":150713310},{"date":"2024-08-23","current":-26.709039,"twenty":-63.123956,"median":-37.878225,"eighty":-10.740213,"marketCap":134701053},{"date":"2024-08-30","current":-30.47318,"twenty":-62.875574,"median":-37.791053,"eighty":-10.88395,"marketCap":153684657},{"date":"2024-09-06","current":-23.484969,"twenty":-62.310952,"median":-37.632017,"eighty":-13.958048,"marketCap":118441183},{"date":"2024-09-13","current":-28.656572,"twenty":-61.520597,"median":-37.39506,"eighty":-19.017097,"marketCap":144523004},{"date":"2024-09-20","current":-27.560062,"twenty":-60.889782,"median":-37.352614,"eighty":-20.363844,"marketCap":138992998},{"date":"2024-09-27","current":-24.761504,"twenty":-59.992238,"median":-37.044217,"eighty":-21.696558,"marketCap":124879101},{"date":"2024-10-04","current":-23.484969,"twenty":-59.885067,"median":-36.618159,"eighty":-21.737099,"marketCap":118441183},{"date":"2024-10-11","current":-22.093874,"twenty":-59.702244,"median":-36.256014,"eighty":-21.195966,"marketCap":111425503},{"date":"2024-10-18","current":-23.40314,"twenty":-59.499033,"median":-36.121676,"eighty":-21.422875,"marketCap":118028496},{"date":"2024-10-25","current":-22.42119,"twenty":-59.246339,"median":-35.506843,"eighty":-21.041389,"marketCap":113076251},{"date":"2024-11-01","current":-20.964631,"twenty":-58.949205,"median":-34.593614,"eighty":-21.041389,"marketCap":105730422},{"date":"2024-11-08","current":-20.522754,"twenty":-58.467774,"median":-33.995368,"eighty":-20.604583,"marketCap":103501912},{"date":"2024-11-15","current":-7.440484,"twenty":-58.205855,"median":-32.960319,"eighty":-20.319817,"marketCap":88892790},{"date":"2024-11-22","current":-6.632186,"twenty":-57.268349,"median":-31.876883,"eighty":-19.75356,"marketCap":79235913},{"date":"2024-11-29","current":-7.461209,"twenty":-55.646905,"median":-31.638328,"eighty":-10.811593,"marketCap":89140402},{"date":"2024-12-06","current":-8.228056,"twenty":-54.314096,"median":-31.509111,"eighty":-9.711562,"marketCap":98302055},{"date":"2024-12-13","current":-1.31262,"twenty":-52.81792,"median":-30.753634,"eighty":-9.005587,"marketCap":15682107},{"date":"2024-12-20","current":-1.540602,"twenty":-48.999152,"median":-30.455494,"eighty":-8.411081,"marketCap":18405842},{"date":"2024-12-27","current":-1.658046,"twenty":-48.426621,"median":-29.978384,"eighty":-8.228056,"marketCap":19808978},{"date":"2025-01-03","current":-1.609687,"twenty":-47.997222,"median":-29.785815,"eighty":-7.657262,"marketCap":19231216},{"date":"2025-01-10","current":-1.457699,"twenty":-47.144687,"median":-29.245398,"eighty":-7.393795,"marketCap":17415393},{"date":"2025-01-17","current":-1.457699,"twenty":-44.916349,"median":-28.653863,"eighty":-7.183487,"marketCap":17415393},{"date":"2025-01-24","current":-1.59587,"twenty":-43.761983,"median":-28.638191,"eighty":-7.010773,"marketCap":19066141},{"date":"2025-01-31","current":-1.561327,"twenty":-43.745005,"median":-28.566935,"eighty":-6.6764,"marketCap":18653454},{"date":"2025-02-07","current":-1.526784,"twenty":-43.24863,"median":-27.889204,"eighty":-6.348881,"marketCap":18240767},{"date":"2025-02-14","current":-1.609687,"twenty":-42.503822,"median":-27.789183,"eighty":-5.849231,"marketCap":19231216},{"date":"2025-02-21","current":-1.575144,"twenty":-42.386727,"median":-27.612716,"eighty":-5.677137,"marketCap":18818529},{"date":"2025-02-28","current":-1.54751,"twenty":-42.123561,"median":-27.159099,"eighty":-5.235169,"marketCap":18488379},{"date":"2025-03-07","current":-1.526784,"twenty":-42.013202,"median":-26.709039,"eighty":-5.079111,"marketCap":18240767},{"date":"2025-03-14","current":-4.449091,"twenty":-41.962266,"median":-26.52242,"eighty":-4.902715,"marketCap":53154092},{"date":"2025-03-21","current":-7.633919,"twenty":-41.885863,"median":-26.463551,"eighty":-4.893488,"marketCap":124361854},{"date":"2025-03-28","current":-5.06435,"twenty":-41.817949,"median":-26.005308,"eighty":-4.799924,"marketCap":82501776},{"date":"2025-04-04","current":-5.919092,"twenty":-41.665143,"median":-25.710723,"eighty":-4.841604,"marketCap":96426126},{"date":"2025-04-11","current":-4.538149,"twenty":-41.597229,"median":-25.473418,"eighty":-4.783424,"marketCap":73929597},{"date":"2025-04-17","current":-5.235298,"twenty":-41.597229,"median":-25.219748,"eighty":-4.791246,"marketCap":85286646},{"date":"2025-04-25","current":-4.61561,"twenty":-41.512337,"median":-24.761504,"eighty":-4.727795,"marketCap":75191492},{"date":"2025-05-02","current":-5.475694,"twenty":-41.298141,"median":-24.40964,"eighty":-4.781468,"marketCap":89202869},{"date":"2025-05-09","current":-4.535478,"twenty":-40.703923,"median":-23.894115,"eighty":-4.754506,"marketCap":73886084},{"date":"2025-05-16","current":-4.092569,"twenty":-40.111614,"median":-23.509518,"eighty":-4.701084,"marketCap":76409872},{"date":"2025-05-23","current":-3.924764,"twenty":-39.899383,"median":-23.40314,"eighty":-4.546794,"marketCap":73276893},{"date":"2025-05-30","current":-3.631106,"twenty":-39.899383,"median":-22.993995,"eighty":-4.534221,"marketCap":67794181},{"date":"2025-06-06","current":-3.514575,"twenty":-39.885461,"median":-22.735979,"eighty":-4.503786,"marketCap":65618501},{"date":"2025-06-13","current":-3.551865,"twenty":-39.7837,"median":-22.503019,"eighty":-4.258784,"marketCap":66314718},{"date":"2025-06-20","current":-3.258207,"twenty":-39.75913,"median":-22.404825,"eighty":-4.158521,"marketCap":60832005},{"date":"2025-06-27","current":-3.311811,"twenty":-39.663708,"median":-22.077508,"eighty":-4.077653,"marketCap":61832818},{"date":"2025-07-03","current":-2.633601,"twenty":-39.550025,"median":-21.823837,"eighty":-3.980044,"marketCap":49170362},{"date":"2025-07-11","current":-3.360754,"twenty":-39.440965,"median":-21.455606,"eighty":-3.896797,"marketCap":62746603},{"date":"2025-07-18","current":-3.528559,"twenty":-39.386585,"median":-21.072854,"eighty":-3.646022,"marketCap":65879582},{"date":"2025-07-25","current":-3.752298,"twenty":-39.349611,"median":-20.964631,"eighty":-3.646022,"marketCap":70056887},{"date":"2025-08-01","current":-3.845523,"twenty":-39.3019,"median":-20.547303,"eighty":-3.685176,"marketCap":71797431},{"date":"2025-08-08","current":-4.353598,"twenty":-39.293948,"median":-20.408193,"eighty":-3.727127,"marketCap":81283395},{"date":"2025-08-15","current":-4.169718,"twenty":-39.274289,"median":-19.933584,"eighty":-3.76778,"marketCap":94285206},{"date":"2025-08-22","current":-3.772796,"twenty":-39.254519,"median":-19.688096,"eighty":-3.760497,"marketCap":85310069},{"date":"2025-08-29","current":-3.813716,"twenty":-39.233455,"median":-10.865861,"eighty":-3.760497,"marketCap":86235341},{"date":"2025-09-05","current":-4.177901,"twenty":-39.220244,"median":-10.526074,"eighty":-3.773614,"marketCap":94470260},{"date":"2025-09-12","current":-3.764612,"twenty":-39.204768,"median":-9.709606,"eighty":-3.773614,"marketCap":85125014},{"date":"2025-09-19","current":-3.314496,"twenty":-39.138888,"median":-9.122923,"eighty":-3.737606,"marketCap":74947023},{"date":"2025-09-26","current":-3.199921,"twenty":-39.116968,"median":-8.741579,"eighty":-3.623336,"marketCap":72356262},{"date":"2025-10-03","current":-3.34314,"twenty":-39.09097,"median":-8.428681,"eighty":-3.551865,"marketCap":75594714},{"date":"2025-10-10","current":-3.494542,"twenty":-39.075273,"median":-8.291789,"eighty":-3.534152,"marketCap":79018220},{"date":"2025-10-17","current":-3.109897,"twenty":-39.027886,"median":-7.962078,"eighty":-3.498549,"marketCap":70320664},{"date":"2025-10-24","current":-2.897115,"twenty":-38.940184,"median":-7.633919,"eighty":-3.482878,"marketCap":65509250},{"date":"2025-10-31","current":-2.909391,"twenty":-38.804612,"median":-7.450846,"eighty":-3.374238,"marketCap":65786832},{"date":"2025-11-07","current":-2.983046,"twenty":-38.663931,"median":-7.254628,"eighty":-3.361323,"marketCap":67452321},{"date":"2025-11-14","current":-2.621936,"twenty":-38.6419,"median":-7.20399,"eighty":-3.333221,"marketCap":67082212},{"date":"2025-11-21","current":-3.258434,"twenty":-38.625998,"median":-7.137979,"eighty":-3.315314,"marketCap":83366998},{"date":"2025-11-28","current":-3.594765,"twenty":-38.625995,"median":-6.963795,"eighty":-3.314496,"marketCap":91972026},{"date":"2025-12-05","current":-3.276516,"twenty":-38.456214,"median":-6.708179,"eighty":-3.314142,"marketCap":83829634},{"date":"2025-12-12","current":-2.961884,"twenty":-38.413768,"median":-6.632186,"eighty":-3.290836,"marketCap":75779768},{"date":"2025-12-19","current":-2.857006,"twenty":-38.350099,"median":-6.354912,"eighty":-3.258434,"marketCap":73096480},{"date":"2025-12-26","current":-3.066761,"twenty":-38.300453,"median":-6.221623,"eighty":-3.198527,"marketCap":78463057},{"date":"2026-01-02","current":-2.857006,"twenty":-38.248873,"median":-6.028218,"eighty":-3.184173,"marketCap":73096480},{"date":"2026-01-09","current":-2.846157,"twenty":-38.210281,"median":-5.866832,"eighty":-3.139814,"marketCap":72818898},{"date":"2026-01-16","current":-2.560456,"twenty":-38.170115,"median":-5.764162,"eighty":-3.103963,"marketCap":65509250},{"date":"2026-01-23","current":-2.379633,"twenty":-38.109126,"median":-5.691463,"eighty":-3.066761,"marketCap":60882891},{"date":"2026-01-30","current":-1.869712,"twenty":-37.999948,"median":-5.513005,"eighty":-3.019747,"marketCap":47836557},{"date":"2026-02-06","current":-1.663573,"twenty":-37.887707,"median":-5.323443,"eighty":-2.9876,"marketCap":42562507},{"date":"2026-02-13","current":-1.638258,"twenty":-37.814908,"median":-5.250814,"eighty":-2.957395,"marketCap":41914817},{"date":"2026-02-20","current":-1.89141,"twenty":-37.791053,"median":-5.231258,"eighty":-2.930623,"marketCap":48391720},{"date":"2026-02-27","current":-1.591244,"twenty":-37.763222,"median":-5.212816,"eighty":-2.89957,"marketCap":40711963},{"date":"2026-03-06","current":-1.450202,"twenty":-37.64792,"median":-5.171192,"eighty":-2.886661,"marketCap":37103403},{"date":"2026-03-13","current":-1.565929,"twenty":-37.601604,"median":-5.067362,"eighty":-2.872563,"marketCap":40064273},{"date":"2026-03-20","current":-1.452342,"twenty":-37.462974,"median":-5.060142,"eighty":-2.848327,"marketCap":39164381},{"date":"2026-03-27","current":-1.345905,"twenty":-37.39506,"median":-5.023312,"eighty":-2.81779,"marketCap":36294178},{"date":"2026-04-02","current":-1.373373,"twenty":-37.39506,"median":-5.008257,"eighty":-2.777444,"marketCap":37034876},{"date":"2026-04-10","current":-1.383673,"twenty":-37.352614,"median":-4.96552,"eighty":-2.744896,"marketCap":37312637},{"date":"2026-04-17","current":-1.369939,"twenty":-37.352614,"median":-4.878764,"eighty":-2.677991,"marketCap":36942288},{"date":"2026-04-24","current":-1.321871,"twenty":-37.289369,"median":-4.834638,"eighty":-2.621936,"marketCap":35646068},{"date":"2026-05-01","current":-1.266936,"twenty":-37.075389,"median":-4.791246,"eighty":-2.520675,"marketCap":34164673},{"date":"2026-05-08","current":-1.304704,"twenty":-37.013045,"median":-4.759848,"eighty":-2.379633,"marketCap":35183132},{"date":"2026-05-15","current":-1.29097,"twenty":-36.657918,"median":-4.726862,"eighty":-1.989055,"marketCap":34812783},{"date":"2026-05-22","current":-0.952489,"twenty":-36.618159,"median":-4.701084,"eighty":-1.869712,"marketCap":28609441},{"date":"2026-05-29","current":-0.967902,"twenty":-36.524547,"median":-4.684546,"eighty":-1.778577,"marketCap":29072377},{"date":"2026-06-05","current":-0.961737,"twenty":-36.333397,"median":-4.581202,"eighty":-1.73518,"marketCap":28887203},{"date":"2026-06-12","current":-0.752128,"twenty":-36.234746,"median":-4.538149,"eighty":-1.677316,"marketCap":22591274},{"date":"2026-06-18","current":-1.174429,"twenty":-36.1867,"median":-4.529194,"eighty":-1.658046,"marketCap":35275719},{"date":"2026-06-26","current":-1.508594,"twenty":-36.138654,"median":-4.51746,"eighty":-1.640428,"marketCap":45312880},{"date":"2026-07-02","current":-1.661705,"twenty":-35.994244,"median":-4.482916,"eighty":-1.622122,"marketCap":49911799},{"date":"2026-07-10","current":-1.684222,"twenty":-35.726787,"median":-4.41968,"eighty":-1.609687,"marketCap":50588111},{"date":"2026-07-17","current":-1.414026,"twenty":-35.527938,"median":-4.351268,"eighty":-1.601689,"marketCap":42472371},{"date":"2026-07-24","current":-1.202372,"twenty":-35.095242,"median":-4.262561,"eighty":-1.59587,"marketCap":36115042},{"date":"2026-07-31","current":-1.134823,"twenty":-34.627571,"median":-4.241728,"eighty":-1.588961,"marketCap":34086107},{"date":"2026-08-07","current":-1.242902,"twenty":-34.501534,"median":-4.181454,"eighty":-1.572341,"marketCap":37332403},{"date":"2026-08-14","current":-1.459615,"twenty":-34.113333,"median":-4.141074,"eighty":-1.56639,"marketCap":44298951},{"date":"2026-08-21","current":-1.275295,"twenty":-34.018436,"median":-4.117333,"eighty":-1.548892,"marketCap":38704885},{"date":"2026-08-28","current":-1.315148,"twenty":-33.795627,"median":-4.092569,"eighty":-1.540602,"marketCap":39914413},{"date":"2026-09-04","current":-1.265332,"twenty":-33.11242,"median":-4.089924,"eighty":-1.53948,"marketCap":38402503},{"date":"2026-09-11","current":-1.235442,"twenty":-32.960319,"median":-4.048287,"eighty":-1.533693,"marketCap":37495358},{"date":"2026-09-18","current":-1.270314,"twenty":-32.304293,"median":-4.022407,"eighty":-1.526784,"marketCap":38553694},{"date":"2026-09-25","current":-1.255369,"twenty":-32.045859,"median":-3.964385,"eighty":-1.512967,"marketCap":38100121},{"date":"2026-10-01","current":-1.479542,"twenty":-31.775497,"median":-3.946365,"eighty":-1.506059,"marketCap":44903715}],"updateTime":1790946692491},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CRVO\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2644088933","title":"CervoMed Receives Notice of Allowance for Neflamapimod Patent in Dementia With Lewy Bodies","url":"https://stock-news.laohu8.com/highlight/detail?id=2644088933","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644088933?lang=en_us&edition=fundamental","pubTime":"2026-06-18 19:36","pubTimestamp":1781782573,"startTime":"0","endTime":"0","summary":"CervoMed  received a notice of allowance from the US Patent and Trademark Office related to a patent application for the use of its drug candidate, neflamapimod, for the treatment of dementia with Lewy bodies, the company said Thursday.The patent is expected to cover the treatment of dementia with Lewy bodies without substantial Alzheimer's disease-like tau pathology and is expected to provide intellectual property protection into 2042, with the potential for additional patent term extension, CervoMed said.CervoMed said there are currently no approved treatments for dementia with Lewy bodies in the United States or the European Union.Shares of CervoMed were up more than 5% in Thursday pre-bell activity.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CRVO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644970054","title":"CervoMed - Patent Expected to Provide Ip Protection Into 2042","url":"https://stock-news.laohu8.com/highlight/detail?id=2644970054","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644970054?lang=en_us&edition=fundamental","pubTime":"2026-06-18 19:02","pubTimestamp":1781780575,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260618:nFWN42Q0PA:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","CRVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644700348","title":"CervoMed Secures New U.S. Patent Protecting Use of Neflamapimod in Pure Dementia With Lewy Body Patients Into 2042","url":"https://stock-news.laohu8.com/highlight/detail?id=2644700348","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644700348?lang=en_us&edition=fundamental","pubTime":"2026-06-18 19:02","pubTimestamp":1781780575,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260618:nFWN42Q0PA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CRVO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644355700","title":"CervoMed wins U.S. patent allowance for neflamapimod use in pure Lewy body dementia into 2042","url":"https://stock-news.laohu8.com/highlight/detail?id=2644355700","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644355700?lang=en_us&edition=fundamental","pubTime":"2026-06-18 19:01","pubTimestamp":1781780503,"startTime":"0","endTime":"0","summary":"CervoMed received a USPTO notice of allowance for a US patent covering neflamapimod use in “pure” dementia with Lewy bodies patients.The patent targets DLB patients without substantial Alzheimer’s-like tau pathology, defined by plasma pTau levels or brain imaging.Intellectual property protection is expected to run into 2042, with potential extension through patent term extension.Neflamapimod has completed a Phase 2b RewinD-LB trial; Phase 3 timing depends on partnership or additional financing.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260618:nNDL5dCSr6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NDAQ","IE00BN0W2T93.GBP","IE00B64PRP62.GBP","SG9999014039.USD","LU2210150020.SGD","SG9999014021.USD","IE00BN0W2V16.EUR","BK4139","IE00BKPKM429.USD","SG9999014005.SGD","LU0314104364.USD","SG9999014013.SGD","IE00B3QW5Z07.USD","LU2210149790.SGD","CRVO","BK4112","IE00BGHQF748.EUR","LU2095319765.USD","BK4588","IE00BN0W2W23.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644376485","title":"Top Midday Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2644376485","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644376485?lang=en_us&edition=fundamental","pubTime":"2026-06-17 01:53","pubTimestamp":1781632404,"startTime":"0","endTime":"0","summary":"Space Exploration Technologies  has agreed to acquire Anysphere, which operates artificial intelligence coding agent Cursor, in a deal valued at about $60 billion.Shares jumped 10% intraday, boosting its market value above that of Amazon . More than 240 million shares traded intraday, compared with a daily average of about 384.9 million.CervoMed  shares soared 115% after the company reported to the Securities and Exchange Commission an insider stock purchase worth $3 million late Monday.Over 174.2 million shares traded intraday versus a daily average of roughly 118,000.Netflix  is one of several media companies interested in acquiring Lionsgate Studios , Semafor reported Tuesday, citing a person familiar with the matter.Shares of Lionsgate rose 10% as intraday trading volume grew to over 10.4 million from a daily average of about 3.3 million.Price: 211.93, Change: +19.43, Percent Change: +10.09","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SG9999004303.SGD","LU0109391861.USD","LU2362540622.SGD","LU2543165471.USD","NFLP","SPCM","LU0942090050.USD","LU2237957902.USD","BK4598","LU1988902786.USD","LU2108987350.USD","LU1674673428.USD","LU1366192091.USD","LU0719512351.SGD","LU2361045086.USD","LU0082616367.USD","LU0127658192.USD","SGXZ23171101.USD","IE00BWXC8680.SGD","SPCH","LU1548497426.USD","LU1814569148.SGD","LU0353189763.USD","LU0079474960.USD","LU1267930730.SGD","BK4089","IE00B19Z9505.USD","LU2461242641.AUD","SSPC","LU1069344957.HKD","LU2361044949.HKD","LU2237957811.SGD","NFLU","SGXZ51526630.SGD","LU0210533765.USD","LU1823568750.SGD","LU0077335932.USD","LU0642271901.SGD","LU1435385759.SGD","LU1429558221.USD","LU1720051108.HKD","LU0708995401.HKD","BK4532","LU0234570918.USD","LU1989764664.SGD","LU2552382132.HKD","LU0097036916.USD","LU0882574139.USD","LU0210536198.USD","LU1316542783.SGD","LU2087625088.SGD","LU0106261372.USD","SGXZ81514606.USD","SPCX","LU0198837287.USD","LU0225283273.USD","LU2860962120.EUR","LU2896262040.SGD","SPAL","IE00BKPKM429.USD","IE00BZ1G4Q59.USD","IE00BKVL7J92.USD","LU0320765059.SGD","LU1035775433.USD","LU2362541513.USD","SPCF","IE00BQXX3F31.USD","NFLW","BK4548","NFXS","SGXZ99366536.SGD","IE00B19Z8W00.USD","BK4534","BK4551","BK4108","LU0786609619.USD","LU2326559502.SGD","BK4527","LU1674673691.USD","BK4581","BK4587","BK4585","LU0256863811.USD","LU0256863902.USD","LU2552382215.SGD","BK4588","SNK","IE00BKDWB100.SGD","LU2264538146.SGD","SPCU","SPAX","LU0868494708.USD","LU1720051017.SGD","LU0353189680.USD","SPCG","LU1046421795.USD","BK4566","LU0006306889.USD","LU0215105999.USD","BK4524","LU0203202063.USD","LU0203201768.USD","LU1127390331.HKD","NFLY","IE00BQXX3D17.EUR","LU0868494617.USD","LION","LU0417517546.SGD","LU1778281490.HKD","CRVO","LU0234572021.USD","LU0672654240.SGD","LOFF","LU2361044865.SGD","BK4139","LU2362541273.HKD","LU2552382058.USD","LU1232071149.USD","BK4507","NFXL","NFLX","LU2357305700.SGD","LU1064131342.USD","SPCQ","IE00B19Z8X17.USD","IE00BQXX3C00.GBP","IE00B1XK9C88.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643737687","title":"CervoMed Jumps 29% Pre-Bell After Reporting to SEC Insider Purchase Worth $3 Million Late Monday","url":"https://stock-news.laohu8.com/highlight/detail?id=2643737687","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643737687?lang=en_us&edition=fundamental","pubTime":"2026-06-16 16:31","pubTimestamp":1781598660,"startTime":"0","endTime":"0","summary":"CervoMed Jumps 29% Pre-Bell After Reporting to SEC Insider Purchase Worth $3 Million Late Monday","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","CRVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643780240","title":"Major Insider Move at CervoMed Signals Strong Confidence From the Top","url":"https://stock-news.laohu8.com/highlight/detail?id=2643780240","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643780240?lang=en_us&edition=fundamental","pubTime":"2026-06-16 10:13","pubTimestamp":1781576002,"startTime":"0","endTime":"0","summary":"New insider activity at CervoMed ( ($CRVO) ) has taken place on June 15, 2026. Director Joshua Boger has significantly increased his stake in Cervo...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/major-insider-move-at-cervomed-signals-strong-confidence-from-the-top-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/major-insider-move-at-cervomed-signals-strong-confidence-from-the-top-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CRVO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643978168","title":"CervoMed Posts Updated Investor Presentation and Business Overview","url":"https://stock-news.laohu8.com/highlight/detail?id=2643978168","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643978168?lang=en_us&edition=fundamental","pubTime":"2026-06-16 06:37","pubTimestamp":1781563062,"startTime":"0","endTime":"0","summary":"The latest announcement is out from CervoMed ( ($CRVO) ). CervoMed Inc. disclosed that summary information about its business, clinical studies, de...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/cervomed-posts-updated-investor-presentation-and-business-overview?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/cervomed-posts-updated-investor-presentation-and-business-overview?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","CRVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643789987","title":"CervoMed beneficial owner Joshua S. Boger acquires 955,414 common shares for $2,999,999.96","url":"https://stock-news.laohu8.com/highlight/detail?id=2643789987","media":"Reuters","labels":["shareholding","insiderTrades","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643789987?lang=en_us&edition=fundamental","pubTime":"2026-06-16 05:38","pubTimestamp":1781559490,"startTime":"0","endTime":"0","summary":"CervoMed director Joshua S. Boger reported a trust purchase of 955,414 common shares at USD 3.14 per share.Trust holdings rose to 1,795,865 shares held indirectly.The filing also shows indirect ownership of 955,414 Series B warrants and 955,414 Series C warrants.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cervomed Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 15, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260615:nNDL2KBP70:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"CervoMed beneficial owner Joshua S. Boger acquires 955,414 common shares for $2,999,999.96","news_tag":"shareholding,insiderTrades,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRVO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642298379","title":"CervoMed to Participate in the H.C. Wainwright 7th Annual Neuro Perspectives Expert Summit","url":"https://stock-news.laohu8.com/highlight/detail?id=2642298379","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642298379?lang=en_us&edition=fundamental","pubTime":"2026-06-12 19:30","pubTimestamp":1781263800,"startTime":"0","endTime":"0","summary":"BOSTON, June  12, 2026  (GLOBE NEWSWIRE) -- CervoMed Inc. (NASDAQ: CRVO), a clinical-stage biotechnology company developing treatments for age-related brain disorders (CervoMed or the Company), today ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/06/12/3310989/0/en/CervoMed-to-Participate-in-the-H-C-Wainwright-7th-Annual-Neuro-Perspectives-Expert-Summit.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4211","SMMF","CRVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642590237","title":"Roth MKM Reaffirms Their Buy Rating on CervoMed (CRVO)","url":"https://stock-news.laohu8.com/highlight/detail?id=2642590237","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642590237?lang=en_us&edition=fundamental","pubTime":"2026-06-12 06:15","pubTimestamp":1781216112,"startTime":"0","endTime":"0","summary":"In a report released today, Boobalan Pachaiyappan from Roth MKM reiterated a Buy rating on CervoMed, with a price target of $9.00. According to Tip...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/roth-mkm-reaffirms-their-buy-rating-on-cervomed-crvo-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/roth-mkm-reaffirms-their-buy-rating-on-cervomed-crvo-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CRVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642425590","title":"CervoMed Announces Private Placement to Advance Neurology Pipeline","url":"https://stock-news.laohu8.com/highlight/detail?id=2642425590","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642425590?lang=en_us&edition=fundamental","pubTime":"2026-06-10 19:57","pubTimestamp":1781092650,"startTime":"0","endTime":"0","summary":"CervoMed ( ($CRVO) ) has provided an announcement. On June 9 and 10, 2026, CervoMed announced a definitive securities purchase agreement for a priv...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/cervomed-announces-private-placement-to-advance-neurology-pipeline?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/cervomed-announces-private-placement-to-advance-neurology-pipeline?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CRVO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642423499","title":"CervoMed releases corporate presentation highlighting neflamapimod Phase 2b efficacy signal in dementia with Lewy bodies","url":"https://stock-news.laohu8.com/highlight/detail?id=2642423499","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642423499?lang=en_us&edition=fundamental","pubTime":"2026-06-10 19:42","pubTimestamp":1781091746,"startTime":"0","endTime":"0","summary":"CervoMed highlighted Phase 2b data in dementia with Lewy bodies showing DP Batch B met exposure targets with clinically meaningful efficacy.CDR-SB improved versus placebo at 16 weeks, with a -1.12 difference in the planned Phase 3 population excluding AD co-pathology.Over 32 weeks, DP Batch B showed a -1.20 CDR-SB difference versus DP Batch A, described as an 89% reduction in decline.Progression risk fell with DP Batch B versus placebo, hazard ratio 0.49; versus DP Batch A, hazard ratio 0.46.Phase 3 planning calls for a single 32-week trial in about 300 patients using pTau181 under 21 pg/mL, with 50 mg TID dosing.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cervomed Inc. published the original content used to generate this news brie","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260610:nNDL53Tp6Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CRVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642423172","title":"CervoMed announces $10.5M private placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2642423172","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642423172?lang=en_us&edition=fundamental","pubTime":"2026-06-10 19:41","pubTimestamp":1781091674,"startTime":"0","endTime":"0","summary":"CervoMed (CRVO) announced that it has entered into a definitive securities purchase agreement for a private placement, from which the company antic...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cervomed-announces-10-5m-private-placement-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cervomed-announces-10-5m-private-placement-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","CRVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642423655","title":"CervoMed prices unregistered $10.5 million private placement at $3.14 per unit","url":"https://stock-news.laohu8.com/highlight/detail?id=2642423655","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642423655?lang=en_us&edition=fundamental","pubTime":"2026-06-10 19:30","pubTimestamp":1781091048,"startTime":"0","endTime":"0","summary":"CervoMed priced an unregistered private placement expected to raise about USD 10.5 million in upfront gross proceeds.Deal sells 3,360,377 units at USD 3.14 per common-share unit, or USD 3.139 per pre-funded-warrant unit.Each unit includes common stock or a pre-funded warrant, one Series B warrant, one Series C warrant.Warrants could add up to about USD 21.7 million if fully exercised for cash; Series B strike USD 3.32, Series C strike USD 3.14.Proceeds extend cash runway into Q2 2027; funding supports partnering to advance neflamapimod into Phase 3 in dementia with Lewy bodies.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260610:nNDL8Hnr7j:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014013.SGD","LU2210149790.SGD","IE00BGHQF748.EUR","IE00BN0W2T93.GBP","SG9999014021.USD","IE00BN0W2V16.EUR","CRVO","IE00BN0W2W23.USD","LU2095319765.USD","NDAQ","LU0314104364.USD","BK4112","BK4585","IE00BKPKM429.USD","LU2210150020.SGD","IE00B3QW5Z07.USD","SG9999014039.USD","BK4139","IE00B64PRP62.GBP","SG9999014005.SGD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642572423","title":"CervoMed - Announces Private Placement With Anticipated Gross Proceeds of $10.5 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2642572423","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642572423?lang=en_us&edition=fundamental","pubTime":"2026-06-10 19:30","pubTimestamp":1781091000,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260610:nTUA1T0BHV:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CRVO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642233104","title":"CervoMed Announces Private Placement Financing and Plan to Focus on Strategic Partnering to Advance Neflamapimod Into Phase 3 for Dementia With Lewy Bodies","url":"https://stock-news.laohu8.com/highlight/detail?id=2642233104","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642233104?lang=en_us&edition=fundamental","pubTime":"2026-06-10 19:30","pubTimestamp":1781091000,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260610:nTUA1T0BHV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","CRVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642042352","title":"Press Release: CervoMed Announces Private Placement Financing and Plan to Focus on Strategic Partnering to Advance Neflamapimod into Phase 3 for Dementia with Lewy Bodies","url":"https://stock-news.laohu8.com/highlight/detail?id=2642042352","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642042352?lang=en_us&edition=fundamental","pubTime":"2026-06-10 19:30","pubTimestamp":1781091000,"startTime":"0","endTime":"0","summary":"Additional funding will extend anticipated runway into second quarter of 2027. Strategic priority is to establish a partnership to advance neflamapimod into Phase 3 in dementia with Lewy bodies. Anticipated pipeline milestones over next six months include obtaining 24-week biomarker and clinical data from Phase 2a trial evaluating neflamapimod in nonfluent variant primary progressive aphasia and initiation of EXPERTS-ALS Phase 2a trial. Financing includes substantial participation from insiders and leading institutional healthcare investors. BOSTON, June 10, 2026  -- CervoMed Inc. , a clinical-stage biotechnology company developing treatments for age-related brain disorders , today announced that it has entered into a definitive securities purchase agreement for a private placement, from which the Company anticipates upfront gross proceeds of approximately $10.5 million, before deducting offering-related fees and expenses.Dr. Joshua S. Boger added: \"DLB is the second most common type o","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0055631609.USD","BK4097","LU1543694498.USD","LU0788109121.HKD","LU0205194284.USD","LU2229751404.USD","BK4132","LU0240878834.USD","CRVO","LU0345774391.USD","SG9999001143.SGD","DLB","BK4017","BK4205","BK4161","LU0205193047.USD","LU1165135440.EUR","BK4567","SG9999002521.SGD","AD","LU2089279066.USD","A","B","IE00BN0W2T93.GBP","LU0345774631.USD","LU2413666699.HKD","LU1430597077.USD","LU1721428933.USD","LU0345781412.USD","LU0498741114.HKD","LU0496367417.USD","LU1023059493.AUD","LU0612318971.USD","LU0330918003.SGD","LU2041044095.USD","LU0345780521.USD","BK4588","BK4233","LU0630314457.HKD","LU0345780950.USD","LU0498741890.SGD","LU0300736492.USD","BK4139","LU0345780281.USD","LU0348723411.USD","LU0654597011.USD","BU","UK","LU0612318385.USD","LU0724618789.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642612994","title":"CervoMed Shareholders Back Board, Pay and Incentive Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2642612994","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642612994?lang=en_us&edition=fundamental","pubTime":"2026-06-09 18:35","pubTimestamp":1781001323,"startTime":"0","endTime":"0","summary":"CervoMed ( ($CRVO) ) has shared an announcement. At its 2026 Annual Meeting of Stockholders, held on June 8, 2026, CervoMed Inc. reported that hold...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/cervomed-shareholders-back-board-pay-and-incentive-plan?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/cervomed-shareholders-back-board-pay-and-incentive-plan?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","CRVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642932469","title":"CervoMed shareholders approve Amendment No. 1 to 2025 equity incentive plan at annual meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2642932469","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642932469?lang=en_us&edition=fundamental","pubTime":"2026-06-09 18:05","pubTimestamp":1780999547,"startTime":"0","endTime":"0","summary":"CervoMed held its annual shareholder meeting on June 8, 2026.Shareholders adopted an amendment to the 2025 Equity Incentive Plan.Shareholders also backed the slate of eight directors for the next term.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cervomed Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 09, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260609:nNDL79Vfg9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CRVO"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":4,"totalSize":106,"code":"91000000","status":"200"}]}}